Yagna PR Jarajapu, MPharm, MS, PhD, FAHA
Associate Professor
16 Sudro Hall
Phone 701.231.8843
Fax 701.231.8333
E-mail Yagna.Jarajapu@ndsu.edu
Teaching
Pharmacogenomics (PSCI417) and Neuropharmacology (PSCI 415) for Pharm D students.
Research Interests
- Role of the Beta-splice Variant of Telomerase Reverse Transcriptase in the Vasoreparative Dysfunction of Diabetic Stem/Progenitor Cells.
- Targeting Alamandine/MrgD Axis for Aging-Associated Vascular Dementia.
- Pharmacology of Mas Receptor(s) in the Aging-Associated Leaky Gut and Inflammation.
Education
2002 Ph.D. Glasgow Caledonian University, UK
1998 M.Sc. University of Strathclyde, UK
1993 M.Pharm. Andhra University, India
1990 B.Pharm Andhra University, India
Awards/Honors
2003 and 2006 ASPET Travel Awards.
2001 British Pharmacological Society Travel Award for Pharmacology-2001, Vancouver, Canada.
2001 European Society for Hypertension Travel Award.
2001 Federation of European Pharmacological Societies (EPHAR) Travel Award.
1997 Academy of Commonwealth Universities (ACU) and Oversees Development Administration (ODA) Shared Scholarship.
1991 University Grants Commission (UGC) Fellowship.
1991 Indian Drug Manufacturers Association (IDMA), G.P.Nair Award.
Professional Appointments
2008-2011 Asst. Instructor, Pharmacology & Therapeutics, University of Florida, Gainesville, FL.
2005-2007 Part-Time, Technology-Scientist, Danish MyoTechnology-USA, Inc.
2005-2007 Post-Doctoral Associate, Wake Forest University, Winston-Salem NC.
2002-2004 Post-Doctoral Associate, Pharmacology & Therapeutics, University of Florida, Gainesville, FL.
1995-1997 Sr. Pharmacologist, Dr. Reddy’s Research Foundation, Hyderabad, India.
Memberships
2020 to date Member of the American Aging Association.
Life member Association of Scientists of Indian Origin in America.
2011-2017 Member of American Association of Colleges of Pharmacy (AACP).
2007 to date Professional member of American Heart Association (AHA).
2002 to date Regular member of American Society of Pharmacology and
Experimental Therapeutics (ASPET).
2006-2011 Member of the Association for Research in Vision and
Ophthalmology (ARVO).
1998-2007 Regular member of the British Pharmacological Society (BPS).
1998-2004 Member of British Physiological Society.
1995-1997 Member of Indian Pharmacological Society (IPS).
Life member Indian Pharmaceutical Graduates Association (IPGA).
Selected Publications
Chittimalli K, Jahan J, Sakamuri A, McAdams ZL, Ericsson AC, Jarajapu YP. (2023). Restoration of gut barrier integrity and restructuring of the gut microbiome in aging by Angiotensin-(1-7). Clin Sci (London). 137(11):913-930.
Jarajapu YP. (2021). Targeting ACE2/Ang-(1-7)/Mas receptor in the vascular progenitor cells for cardiovascular diseases. Mol Pharmacol. 99(1):29-38.
Joshi S, Montes de Oca I, Meghrabi A, Yang CL, Quiroz Olvera J, Garcia CA, Jarajapu YP. (2021) ACE2 Gene Transfer Ameliorates Vasoreparative Dysfunction in CD34+ Cells Derived from Diabetic Older Adults. Clin Sci (London). 135(2):367-385.
Joshi S, Mahoney S, Jesmin J, Pitts L, Hackney KJ, Jarajapu YP. (2020) Blood flow restriction exercise stimulates mobilization of hematopoietic stem/progenitor cells and increases the circulating ACE2 levels in healthy adults. J Appl Physiol (1985). 128(5):1423-1431.
Joshi S, Wollenzien H, Leclerc E, Jarajapu YP. (2019). Hypoxic Regulation of Angiotensin-Converting Enzyme 2 and Mas Receptor in Human CD34+ Cells. J Cell Physiol. 234(11):20420-20431.
Vasam G, Joshi S, Thatcher SE, Bartelmez SH, Cassis LA, Jarajapu YP. (2017). Reversal of bone marrow mobilopathy and enhanced vascular repair by Angiotensin-(1-7) in diabetes. Diabetes. 66(2):505-518.
Follow this link for the full list of publications: http://www.ncbi.nlm.nih.gov/pubmed?term=yagna%20OR%20jarajapu
Current Funding Support
National Institutes of Health and American Heart Association.